Endometriosis and adenomyosis: common and disparate features

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Endometriosis and adenomyosis are diseases of the gynecological profile, which are ectopic endometrioid tissue and have long been considered tangible manifestations of the process. Only recently have scientists begun to put forward a theory about the unequal origin of these pathologies. In endometriosis, the lining of the uterus extends beyond it, mainly to the ovaries, fallopian tubes, and bladder. With adenomyosis, the nodes grow into the muscular wall of her uterus and thicken. They do not go outside the uterus. Both conditions cause severe pain due to local inflammation, swelling and adhesions in the abdominal cavity. The only reliable way to identify the diagnosis of endometriosis is invasive exploratory laparoscopy with biopsy of tissue samples. In contrast, an enlarged uterus with adenomyotic nodules can be assessed even on routine examination, and on ultrasound or MRI they are visualized in the report. Obviously, despite the high frequency of pathophysiological and molecular mechanisms, endometriosis and adenomyosis has rare causes, clinics and effects on the reproductive system of the female body, which significantly reduces the risk and treatment of diseases.

The review provides a comparative characteristic of endometriosis and adenomyosis in terms of prevalence, etiology, pathogenesis, clinical manifestations, effects on fertility and experimental modeling, obtained from domestic and foreign sources.

Understanding the pathophysiology of adenomyosis and endometriosis opens up additional possibilities for diagnosis, prevention, and treatment. The development of new diagnostic methods based on modern high-tech methods allows us to assume a preclinical stage and identify the diagnosis, predict and carry out adequate treatment depending on the histological picture.

Full Text

Restricted Access

About the authors

Viktoriya A. Deryabina

St. Petersburg State Pediatric Medical University

Email: vika.deryabina@mail.ru

Student, Pediatric Faculty

Russian Federation, Saint Petersburg

Tatiana V. Brus

St. Petersburg State Pediatric Medical University

Author for correspondence.
Email: bant.90@mail.ru
SPIN-code: 9597-4953

MD, PhD, Associate Professor of the Department of Pathological Physiology with the Course of Immunopathology

Russian Federation, Saint Petersburg

Sarng S. Pyurveev

St. Petersburg State Pediatric Medical University

Email: dr.purvvev@gmail.ru
SPIN-code: 5915-9767

Assistant of the Department of Pathological Physiology with the Course of Immunopathology

Russian Federation, Saint Petersburg

References

  1. Artymuk NV, Vaulina EN, Zotova OA. Pregnancy and childbirth in patients with endometriosis. Gynecology. 2021;23(1):6–11. (In Russ.) doi: 10.26442/20795696.2021.1.200692
  2. Arutyunyan AF, Gaidukov SN, Kostushov YV. The state of the blood flow in patients with the adenomyosis. Pediatrician (St. Petersburg). 2013;4(2):28–31. (In Russ.) doi: 10.17816/PED4228-31
  3. Arutyunyan AF, Gaydukov SN, Kustarov VN. Contemporary aspects of pathogenetically substantiated therapy of adenomyosis. Pediatrician (St. Petersburg). 2016;7(3):92–97. (In Russ.) doi: 10.17816/PED7392-97
  4. Vasiliev AG, Komyakov BK, Tagirov NS, Musaev SA. Percutaneous nephrolithitripsy in the treatment of coral calculus nephrolithiasis. Herald of North-Western State Medical University named after I.I. Mechnikov. 2009;(4):183–186. (In Russ.)
  5. Gabidullina RI, Kuptsova AI, Koshelnikova EA, et al. Adenomyosis: clinical aspects, impact on fertility and pregnancy outcome. Gynecology. 2020;22(4):55–61. doi: 10.26442/20795696.2020.4.200264
  6. Gurkin YuA. Detskaya i podrostkovaya ginekologiya. Moscow: Meditsinskoe informatsionnoe agentstvo, 2009. 696 p. (In Russ.)
  7. Daubasova ISh. Ehndometrioz kak chastaya patologiya v ginekologii. Vestnik KazNMU. 2013;(3–2):13–14. (In Russ.)
  8. Kononov AV, Mozgovoy SI, Mozgovaya EI, Novikov DG. Endometriosis: theories of origin. Omsk scientific bulletin. 2008;(1–3):32–36. (In Russ.)
  9. Kuksgauz IA, Shekunova EV, Kashkin VA, et al. Assessment criteria of experimental endometrios in rats. Laboratory Animals for Science. 2018;1(4):88–99. (In Russ.) doi: 10.29296/2618723X-2018-04-07
  10. Linde VA, Reznik MV, Tarasenkova VA, Sadykhova EE. Adenomyosis: current notions. Bulletin of the Ivanovo Medical Academy. 2018;23(3):36–39. (In Russ.)
  11. Magalov ISh. Combination of adenomyosis and endometriosis among patients of the gynecologic hospital. World of medicine and biology. 2011;(4):106–109. (In Russ.)
  12. Nepomnyashchikh LM, Lushnikova EL, Pekarev OG, et al. Morphological aspects of internal endometriosis. Siberian Journal of Oncology. 2012;(2):39–44. (In Russ.)
  13. Orazov MR, Dukhin AO, Bikmayeva YR, Shkreli I. Risk factors of external genital endometriosis in women in megapolis on the example of Moscow. Research’n Practical Medicine Journal. 2016;3:125–126. (In Russ.)
  14. Pavlov RV. Role of vascularization and cell environment features of heterotopic tissue in rat modelsendometriosis progress. Journal of obstetrics and women’s diseases. 2006;55(1):80–84. (In Russ.)
  15. Petrosyan MA, Balashova NN, Polyanskikh LS, et al. Vnutribryushinnoe i podkozhnoe modelirovanie ehndometrioza u krys. Journal of obstetrics and women’s diseases. 2016;65(S):19–21. (In Russ.)
  16. Savinov PA, Niauri DA, Kovshova MV. Razrabotka ehksperimentalnoi modeli ehndometrioza, adaptirovannoi k sovremennym khirurgicheskim tekhnologiyam. Vestnik of Saint Petersburg University. Medicine. 2006;1(3):114–119. (In Russ.)
  17. Tagirov NS, Nazarov TH, Vasilev AG, et al. The experience of using percutaneous nephrolithotripsy and contact ureterolithotripsy in the complex treatment of urolithiasis. Preventive and clinical medicine. 2012;(4):30–33. (In Russ.)
  18. Tikhomirov AL. Triggers and prevention of endometriosis. Difficult Patient. 2019;17(8–9):13–19. (In Russ.) doi: 10.24411/2074-1995-2019-10056
  19. Trashkov AP, Brus TV, Vasiliev AG, et al. Biochemical profile of rats with non-alcoholic fatty liver disease of various gravity and its correction with Remaxol. Pediatrician (St. Petersburg). 2017;8(4):78–85. (In Russ.) doi: 10.17816/PED8478-85
  20. Trashkov AP, Vasiliev AG, Kovalenko AL, Tagirov NS. Metabolic therapy of nephrolithiasis in two different rat models of kidney disease. Experimental and clinical pharmacology. 2015;78(3):17–21. (In Russ.)
  21. Trashkov AP, Vasiliev AG, Tsygan NV, et al. Antithrombotic therapy in oncology: contemporary concepts and pending problems. Pediatrician (St. Petersburg). 2012;3(2):3–19. (In Russ.)
  22. Trashkov AP, Panchenko AV, Kayukova ES, et al. Leikemiya P-388 u myshei linii CDF1 kak test-sistema opukhol’-assotsiirovannogo neoangiogeneza i giperkoagulyatsii. Byulleten’ eksperimental’noj biologii i mediciny. 2014;158(10):500–502. (In Russ.)
  23. Trashkov AP, Brus TV, Vasil’ev AG, et al Endothelial dysfunction in the pathogenesis of non-alcoholic fatty liver disease. Russian Biomedical Research. 2017;2(4): 11–17 (In Russ.)
  24. Unanyan AL. Endometriosis and female reproductive health. Obstetrics, Gynecology and Reproduction. 2010;4(3):6–11. (In Russ.)
  25. Khaytsev NV, Vasiliev AG, Trashkov AP, et al. The influence of sex and age upon response of white rats to hypoxic hypoxia. Pediatrician (St. Petersburg). 2015;6(2):71–77. (In Russ.)
  26. Lobanova AD, Khaschenko EP, Uvarova EV, et al. Clinical and laboratory features of different forms of endometriosis in adolescent girls. Pediatric and adolescent reproductive health. 2019;15(4):67–77. (In Russ.)
  27. Tsvelev UV, Bejenar VF, Povzun SА, Fridman DВ. Clinical diagnosis of adenomyosis. Journal of obstetrics and women’s diseases. 2005;54(3):91–98. (In Russ.) doi: 10.17816/JOWD83488
  28. Yarmolinskaya MI, Rusina EI, Khachaturyan AR, Florova MS. Clinical picture and diagnosis of genital endometriosis. Journal of obstetrics and women’s diseases. 2016; 65(5):4–21. (In Russ.) doi: 10.17816/JOWD6554-21
  29. Aleksandrovych V, Bereza T, Sajewicz M, et al. Uterine fibroid: common features of widespread tumor (Review article). Folia medica Cracoviensia. 2015;55(1):61–75.
  30. Antero MF, Ayhan A, Segars J, Shih I-M. Pathology and pathogenesis of adenomyosis. Semin Reprod Med. 2020;38(2–3):108–118. doi: 10.1055/s-0040-1718922
  31. Benagiano G, Brosens I. The endometrium in adenomyosis. Women’s Health. 2012;8(3):301–312. doi: 10.2217/WHE.12.8
  32. Benagiano G, Brosens I, Habiba M. Adenomyosis: a life-cycle approach. Reproductive BioMedicine Online. 2015;30(3):220–232. doi: 10.1016/j.rbmo.2014.11.005
  33. Benagiano G, Brosens I, Habiba M. Structural and molecular features of the endomyometrium in endometriosis and adenomyosis. Human Reproduction Update. 2013;20(3):386–402. doi: 10.1093/humupd/dmt052
  34. Bergeron C, Amant F, Ferenczy A. Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(3):511–521. doi: 10.1016/j.bpobgyn.2006.01.016
  35. Bird CC, McElin TW, Manalo-Estrella P. The elusive adenomyosis of the uterus — revisited. Am J Obstet Gynecol. 1972;112(5):583–593. doi: 10.1016/0002-9378(72)90781-8
  36. Bricou A, Batt RE, Chapron C. Peritoneal fluid flow influences anatomical distribution of endometriotic lesions: Why Sampson seems to be right. Eur J Obstet Gynecol Reprod Biol. 2008;138(2):127–134. doi: 10.1016/j.ejogrb.2008.01.014
  37. Chapron C, Vannuccini S, Santulli P, et al. Diagnosing adenomyosis: an integrated clinical and imaging approach. Hum Reprod Update. 2020;26(3):392–411. doi: 10.1093/humupd/dmz049
  38. Chen Y-J, Li H-Y, Chang Y-L, et al. Suppression of migratory/invasive ability and induction of apoptosis in adenomyosis-derived mesenchymal stem cells by cyclooxygenase-2 inhibitors. Fertility and Sterility. 2010;94(6):1972–1979. doi: 10.1016/j.fertnstert.2010.01.070
  39. Di Donato N, Montanari G, Benfenati A, et al. Prevalence of adenomyosis in women undergoing surgery for endometriosis. Eur J Obstet Gynecol Reprod Biol. 2014;181:289–293. doi: 10.1016/j.ejogrb.2014.08.016
  40. Dougherty CM, Anderson MR. Endometriosis and adenomyosis. Am J Obstet Gynecol. 1964;89(1):23–40. doi: 10.1016/S0002-9378(16)35038-4
  41. Dueholm M. Uterine adenomyosis and infertility, review of reproductive outcome after in vitro fertilization and surgery. Acta Obstet Gynecol Scand. 2017;96(6):715–726. doi: 10.1111/aogs.13158
  42. Fernandez H, Donnadieu A-C. Adénomyose. Journal de Gynécologie Obstétrique et Biologie de La Reproduction. 2007;36(2):179–185. doi: 10.1016/j.jgyn.2006.12.011
  43. Garcia L, Isaacson K. Adenomyosis: review of the literature. J Minim Invasive Gynecol. 2011;18(4):428–437. doi: 10.1016/j.jmig.2011.04.004
  44. García-Solares J, Donnez J, Donnez O, Dolmans M–M. Pathogenesis of uterine adenomyosis: invagination or metaplasia? Fertility and Sterility. 2018;109(3): 371–379. doi: 10.1016/j.fertnstert.2017.12.030
  45. Gargett CE. Uterine stem cells: What is the evidence? Hum Reprod Update. 2007;13(1):87–101. doi: 10.1093/humupd/dml045
  46. Gargett CE, Schwab KE, Deane JA. Endometrial stem/progenitor cells: the first 10 years. Hum Reprod Update. 2016;22(2):137–163. doi: 10.1093/humupd/dmv051
  47. Gordts S, Grimbizis G, Campo R. Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis. Fertility and Sterility. 2018;109(3):380–388. doi: 10.1016/j.fertnstert.2018.01.006
  48. Graziano A, Lo Monte G, Piva I, et al. Diagnostic findings in adenomyosis: a pictorial review on the major concerns. Eur Rev Med Pharmacol Sci. 2015;19(7): 1146–1154.
  49. Gruber TM, Mechsner S. Pathogenesis of endometriosis: the origin of pain and subfertility. Cells. 2021;10(6):1381. doi: 10.3390/cells10061381
  50. Guo S-W. The Pathogenesis of adenomyosis vis-à-vis endometriosis. J Clin Med. 2020;9(2):485–499. doi: 10.3390/jcm9020485
  51. Huang FJ, Kung FT, Chang SY, Hsu TY. Effects of short-course buserelin therapy on adenomyosis: A report of two cases. J Reprod Med Obstet Gynecol. 1999;44(8):741–744.
  52. Kelly HA, Cullen TS. Myomata of the Uterus. WB Saunders, 1909.
  53. Kitawaki J. Adenomyosis: The pathophysiology of an oestrogen-dependent disease. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):493–502. doi: 10.1016/j.bpobgyn.2006.01.010
  54. Kitawaki J, Noguchi T, Amatsu T, et al. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod. 1997;57(3):514–519. doi: 10.1095/biolreprod57.3.514
  55. Kunz G, Beil D, Huppert P, et al. Adenomyosis in endometriosis-prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Reprod. 2005;20(8):2309–2316. doi: 10.1093/humrep/dei021
  56. Kunz G, Noe M, Herbertz M, Leyendecker G. Uterine peristalsis during the follicular phase of the menstrual cycle: effects of oestrogen, antioestrogen and oxytocin. Hum Reprod Update. 1998;4(5):647–654. doi: 10.1093/humupd/4.5.647
  57. Levgur M, Abadi MA, Tucker A. Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet Gynecol. 2000;95(5):688–691. doi: 10.1097/00006250-200005000-00011
  58. Leyendecker G, Bilgicyildirim A, Inacker M, et al. Adenomyosis and endometriosis. Re-visiting their association and further insights into the mechanisms of auto-traumatisation. An MRI study. Arch Gynecol Obstet. 2015;291(4): 917–932. doi: 10.1007/s00404-014-3437-8
  59. Leyendecker G, Kunz G. Endometriose und adenomyose. Zentralblatt Für Gynäkologie. 2005;127(5):288–294. doi: 10.1055/s-2005-836885
  60. Leyendecker G, Kunz G, Noe M, et al. Endometriosis: a dysfunction and disease of the archimetra. Hum Reprod. 1998;4(5):752–762. doi: 10.1093/humupd/4.5.752
  61. Leyendecker G, Wildt L. A new concept of endometriosis and adenomyosis, tissue injury and repair (TIAR). Horm Mol Biol Clin Investig. 2011;5(2):125–142. doi: 10.1515/HMBCI.2011.002
  62. Leyendecker G, Wildt L, Mall G. The pathophysiology of endometriosis and adenomyosis, tissue injury and repair. Arch Gynecol Obstet. 2009;280(4):529–538. doi: 10.1007/s00404-009-1191-0
  63. Marquardt RM, Jeong J-W, Fazleabas AT. Animal models of adenomyosis. Semin Reprod Med. 2020;38 (2–3):168–178. doi: 10.1055/s-0040-1718741
  64. Mehasseb MK, Habiba MA. Adenomyosis uteri: an update. The Obstetrician and Gynaecologist. 2009;11(1):41–47. doi: 10.1576/toag.11.1.41.27467
  65. Mizumoto Y, Furuya K, Makimura N, et al. Gene expression of oxytocin receptor in human ectopic endometrial tissues. Adv Exp Med Biol. 1995;395:491–493.
  66. Panchenko AV, Popovich IG, Egormin PA, et al. Biomarkers of aging, life span and spontaneous carcinogenesis in the wild type and HER-2 transgenic FVB/N female mice. Biogerontology. 2016;17(2):317–324. doi: 10.1007/s10522-015-9611-y
  67. Parrott E, Butterworth M, Green A, et al. Adenomyosis — a result of disordered stromal differentiation. Am J Pathol. 2001;159(2):623–630. doi: 10.1016/S0002-9440(10)61733-6
  68. Rees CO, Rupert IAM, Nederend J, et al. Women with combined adenomyosis and endometriosis on MRI have worse IVF/ICSI outcomes compared to adenomyosis and endometriosis alone: A matched retrospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2022;271: 223–234. doi: 10.1016/j.ejogrb.2022.02.026
  69. Rogers PA, Adamson GD, Al-Jefout M, et al. Research priorities for endometriosis. Reprod Sci. 2017;24(2): 202–226. doi: 10.1177/1933719116654991
  70. Ryan GL, Stolpen A, Van Voorhis BJ. An unusual cause of adolescent dysmenorrhea. Obstetrics and gynecology. 2006;108(4):1017–1022. doi: 10.1097/01.AOG.0000237163.98010.b3
  71. Sampson JA. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 1927;14(4): 422–469. doi: 10.1016/S0002-9378(15)30003-X
  72. Senturk LM, Imamoglu M. Adenomyosis: what is new? Women’s Health. 2015;11(5):717–724. doi: 10.2217/whe.15.60
  73. Signorile PG, Baldi F, Bussani R, et al. Embryologic origin of endometriosis: analysis of 101 human female fetuses. J Cell Physiol. 2012;227(4):1653–1656. doi: 10.1002/jcp.22888
  74. Struble J, Reid S, Bedaiwy MA. Adenomyosis: A clinical review of a challenging gynecologic condition. J Minim Invasive Gynecol. 2016;23(2):164–185. doi: 10.1016/j.jmig.2015.09.018
  75. Szubert M, Koziróg E, Olszak O, et al. Adenomyosis and infertility — review of medical and surgical approaches. Int J Environ Res Public Health. 2021;18(3):1235. doi: 10.3390/ijerph18031235
  76. Tsygan NV, Trashkov AP, Litvinenko IV, et al. Autoimmunity in acute ischemic stroke and the role of blood-brain barrier: the dark side or the light one? Front Med. 2019;13(4):420–426. doi: 10.1007/s11684-019-0688-6
  77. Templeman C, Marshall SF, Ursin G, et al. Adenomyosis and endometriosis in the California Teachers Study. Fertility and Sterility. 2008;90(2):415–424. doi: 10.1016/j.fertnstert.2007.06.027
  78. Van den Bosch T, Van Schoubroeck D. Ultrasound diagnosis of endometriosis and adenomyosis: State of the art. Best Pract Res Clin Obstet Gynaecol. 2018;51: 16–24. doi: 10.1016/j.bpobgyn.2018.01.013
  79. Vannuccini S, Tosti C, Carmona F, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reproductive BioMedicine Online. 2017;35(5):592–601. doi: 10.1016/j.rbmo.2017.06.016
  80. Wang J, Deng X, Yang Y, et al. Expression of GRIM-19 in adenomyosis and its possible role in pathogenesis. Fertility and Sterility. 2016;105(4):1093–1101. doi: 10.1016/j.fertnstert.2015.12.019
  81. Yang G, Im H-J, Wang J-HC. Repetitive mechanical stretching modulates IL-1beta induced COX-2, MMP-1 expression, and PGE2 production in human patellar tendon fibroblasts. Gene. 2005;363:166–172. doi: 10.1016/j.gene.2005.08.006
  82. Zhai J, Vannuccini S, Petraglia F, Giudice LC. Adenomyosis: Mechanisms and Pathogenesis. Semin Reprod Med. 2020;38(2–3):129–143. doi: 10.1055/s-0040-1716687.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. Rationalizing the origin of endometriosis retrograde menstruation theory

Download (133KB)
Indexing metadata
3. Fig. 2. Pathogenesis of adenomyosis: TIAR mechanism. TNF-α — tumor necrosis factor α; IL-1β — interleukin-1β; COX-2 — cyclooxygenase-2; PGE2 — prostaglandin E2; StAR — steroidogenic acute regulatory protein; ER-α — estrogen receptor α; ER-β — estrogen receptor β

Download (143KB)
Indexing metadata
4. Fig. 3. The structure of the reproductive system of rats

Download (133KB)
Indexing metadata

Copyright (c) 2022 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 69634 от 15.03.2021 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies